Uprifosbuvir Uses, Dosage, Side Effects and more
Uprifosbuvir is under investigation in clinical trial NCT02332707 (Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)).
| Trade Name | Uprifosbuvir |
| Generic | Uprifosbuvir |
| Uprifosbuvir Other Names | Uprifosbuvir |
| Type | |
| Formula | C22H29ClN3O9P |
| Weight | Average: 545.91 Monoisotopic: 545.1329942 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
